Book contents
- Leong’s Manual of Diagnostic Biomarkers for Immunohistology
- Leong’s Manual of Diagnostic Biomarkers for Immunohistology
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Plate Section (PDF Only)
- References
Dictionary
Published online by Cambridge University Press: 03 July 2022
Book contents
- Leong’s Manual of Diagnostic Biomarkers for Immunohistology
- Leong’s Manual of Diagnostic Biomarkers for Immunohistology
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Plate Section (PDF Only)
- References
- Type
- Chapter
- Information
- Leong's Manual of Diagnostic Biomarkers for Immunohistology , pp. 285 - 296Publisher: Cambridge University PressPrint publication year: 2022
References
Selected references
Dunn, GP, Andronesi, OC, Cahill, DP. From genomics to the clinic: Biological and translational insights of mutant IDH1/2 in glioma. Neurosurg Focus 2013;34(2):E2.CrossRefGoogle Scholar
Rodriguez, FJ, Vizcaino, MA, Lin, MT. Recent advances on the molecular pathology of glial neoplasms in children and adults. J Mol Diagn 2016;18(5):620–34.Google Scholar
Selected references
Deshpande, V, Sainani, NI, Chung, RT, et al. IgG4-associated cholangitis. Mod Pathol 2009;22:1287–95.Google Scholar
Kamisawa, T, Takuma, K, Anjiki, H, et al. Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis. World J Gastroenterol 2009;15:2357–60.CrossRefGoogle ScholarPubMed
Selected references
Merz, H, Pickers, O, Schrimel, S, et al. Constant detection of surface and cytoplasmic immunoglobulin heavy and light chain expression in formalin-fixed and paraffin-embedded material. J Pathol 1993;170:257–64.CrossRefGoogle ScholarPubMed
Leong, AS-Y, Forbes, IJ. Immunological and histochemical techniques in the study of the malignant lymphomas: A review. Pathology 1982;14:247–54.Google Scholar
Selected references
Li, Y, Pawel, BR, Hill, DA, et al. Pediatric cystic nephroma is morphologically, immunohistochemically, and genetically distinct from adult cystic nephroma. Am J Surg Pathol 2017;41:472–81.Google Scholar
Sangoi, AR, McKenney, JK. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am J Surg Pathol 2010;34:423–32.CrossRefGoogle ScholarPubMed
Selected references
Goto, Y, De Silva, MG, Toscani, A, et al. A novel human insulinoma-associated cDNA, IA-1, encodes a protein with “zinc-finger” DNA-binding motifs. J Biol Chem 1992;267:15252–7.Google Scholar
Rooper, LM, Sharma, R, Li, QK, et al. INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity. Am J Surg Pathol 2017;41:1561–9.Google Scholar
Rosenbaum, JN, Guo, Z, Baus, RM, et al. A novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms. Am J Clin Pathol 2015;144:579–91.Google Scholar
Xie, J, Cai, T, Zhang, H, et al. The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the Cbl-associated protein. Genomics 2002;80:54–61.CrossRefGoogle ScholarPubMed
Selected references
Agaimy, A, Erlenbach-Wünsch, K, Konukiewitz, B, et al. ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Mod Pathol 2013;26:995–1003.Google Scholar
Ahlgren, U, Pfaff, SL, Jessell, TM, et al. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 1997;385(6613):257–60.Google Scholar
Bellizzi, AM. Assigning site of origin in metastatic neuroendocrine neoplasms: A clinically significant application of diagnostic immunohistochemistry. Adv Anat Pathol 2013;20(5):285–314.Google Scholar
Graham, RP, Shreshtha, B, Caron, BL, et al. Islet-1 is a sensitive but not entirely specific marker for pancreatic neuroendocrine neoplasms and their metastases. Am J Surg Pathol 2013;37(3):399–404.Google Scholar
Hermann, G, Konukiewitz, B, Schmitt, A, et al. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: Expression of ISL1, PDX1, NGN3, and CDX2. Virchows Arch 2011;459:147–54.CrossRefGoogle ScholarPubMed
Schmitt, AM, Riniker, F, Anlauf, M, et al. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. Am J Surg Pathol 2008;32(3):420–5.Google Scholar